English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response

Dedic, N., Chen, A., & Deussing, J. M. (2018). The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response. CURRENT MOLECULAR PHARMACOLOGY, 11(1), 4-31. doi:10.2174/1874467210666170302104053.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Dedic, Nina1, Author           
Chen, Alon1, 2, Author           
Deussing, Jan M.1, Author           
Affiliations:
1Dept. Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Max Planck Society, ou_2035294              
2external, ou_persistent22              

Content

show
hide
Free keywords: CORTICOTROPIN-RELEASING-FACTOR; VENTRAL TEGMENTAL AREA; DORSAL RAPHE NUCLEUS; EDINGER-WESTPHAL-NUCLEUS; CENTRAL-NERVOUS-SYSTEM; ANXIETY-LIKE BEHAVIOR; EARLY-LIFE STRESS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; FACTOR-LIKE IMMUNOREACTIVITY; MIDBRAIN DOPAMINE NEURONSBiochemistry & Molecular Biology; Pharmacology & Pharmacy; Corticotropin-releasing factor; urocortin; stress; mouse genetic tools; hypothalamic-pituitary-adrenal (HPA); neuropsychiatric disorders;
 Abstract: Background: Dysregulated stress neurocircuits, caused by genetic and/or environmental changes, underlie the development of many neuropsychiatric disorders. Corticotropin-releasing factor (CRF) is the major physiological activator of the hypothalamic-pituitary-adrenal (HPA) axis and consequently a primary regulator of the mammalian stress response. Together with its three family members, urocortins (UCNs) 1, 2, and 3, CRF integrates the neuroendocrine, autonomic, metabolic and behavioral responses to stress by activating its cognate receptors CRFR1 and CRFR2. Objective: Here we review the past and current state of the CRF/CRFR field, ranging from pharmacological studies to genetic mouse models and virus-mediated manipulations. Results: Although it is well established that CRF/CRFR1 signaling mediates aversive responses, including anxiety and depression-like behaviors, a number of recent studies have challenged this viewpoint by revealing anxiolytic and appetitive properties of specific CRF/CRFR1 circuits. In contrast, the UCN/CRFR2 system is less well understood and may possibly also exert divergent functions on physiology and behavior depending on the brain region, underlying circuit, and/or experienced stress conditions. Conclusion: A plethora of available genetic tools, including conventional and conditional mouse mutants targeting CRF system components, has greatly advanced our understanding about the endogenous mechanisms underlying HPA system regulation and CRF/UCN-related neuronal circuits involved in stress-related behaviors. Yet, the detailed pathways and molecular mechanisms by which the CRF/UCN-system translates negative or positive stimuli into the final, integrated biological response are not completely understood. The utilization of future complementary methodologies, such as cell-type specific Cre-driver lines, viral and optogenetic tools will help to further dissect the function of genetically defined CRF/UCN neurocircuits in the context of adaptive and maladaptive stress responses.

Details

show
hide
Language(s): eng - English
 Dates: 2018
 Publication Status: Issued
 Pages: 28
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show hide
Project name : -
Grant ID : 260463
Funding program : Funding Programme 7 (FP7)
Funding organization : European Commission (EC)
Project name : IntegraMent: Integrated Understanding of Causes and Mechanisms in Mental Disorders
Grant ID : 01ZX1314H
Funding program : (e:med)
Funding organization : -
Project name : medical genome
Grant ID : 01GS08151
Funding program : (01GS08155)
Funding organization : (NGFN-Plus)
Project name : medical genome
Grant ID : -
Funding program : (NGFN-Plus)
Funding organization : -

Source 1

show
hide
Title: CURRENT MOLECULAR PHARMACOLOGY
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: BENTHAM SCIENCE PUBL LTD
Pages: - Volume / Issue: 11 (1) Sequence Number: - Start / End Page: 4 - 31 Identifier: ISSN: 1874-4672